About Catawba Research
Catawba Research is a Healthcare company based in Charlotte (United States) founded in 2014. Provider of clinical trial management services for pharmaceutical and biotechnology companies. The company has 21 employees. Its Indian entity Catawba Research (India) Private Limited reported revenue of ₹9.86 Cr. Catawba Research offers products and services including Trial Management, Clinical Operations, and Therapeutic Expertise. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Celgene, Syneos Health and Medelis WCCT Global; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2014 and based in Charlotte, United States, Catawba Research operates in the clinical research sector. Services encompass full development support across therapeutic areas, including trial management and clinical operations. Adherence to international good clinical practice guidelines and regulatory requirements is maintained. Scientific and regulatory advisory services are provided through an expert advisory board, covering the clinical development process from program design to market authorization.
- Headquarters Charlotte, United States
- Employees 21
- SectorsHealthcare
- Phone•••• ••••
- Website catawbaresearch.com
- Social LinkedIn
- Legal Name Catawba Research (India) Private Limited
- Date of Incorporation 16 Oct, 2019
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹9.86 Cr
FY 2025 · -2% YoY
- Indian entity net profit₹19.8 Lakh
FY 2025 · 2% margin
- Indian entity EBITDA₹24.2 Lakh
FY 2025 · 2% margin
- Investors
- Employee Count21
Associated legal entities of Catawba Research
Catawba Research operates through Catawba Research (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Catawba Research (India) Private Limited CIN U73100MH2019PTC331697 | Active | 16 Oct 2019 | Mumbai, Maharashtra | ₹9.9 Cr | 21 | 3 | View details |
Products & Services of Catawba Research
Catawba Research offers a comprehensive portfolio of products and services, including Trial Management, Clinical Operations, and Therapeutic Expertise.
Manages clinical trials for drug and device development processes
Handles operations and execution of clinical studies worldwide
Provides specialized advice in areas like dermatology and respiratory health
Funding Insights of Catawba Research
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Catawba Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | Seed | – | St. Cloud Capital | – |
1 investors in total: 1 institutional.
Investors in Catawba Research
Catawba Research has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include St. Cloud Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and debt firm focused on manufacturing, distribution, logistics, financial, and multiple sectors | stcloudcapital.com | Los Angeles, United States |
Investor details for Catawba Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Catawba Research (India) Private Limited (Catawba Research)
Catawba Research (India) Private Limited is the primary company behind Catawba Research. The board of Catawba Research (India) Private Limited currently have 3 directors; the longest-serving is Nicolaus Goldstein Joseph, appointed in 2021. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nicolaus Goldstein Joseph DIN 09061534 | Director | 05 Mar 2021 | 5 yrs 8 mo | Catawba Research (India) Private Limited |
| Andrew Flint Silverman DIN 10424425 | Director | 19 Dec 2023 | 2 yrs 10 mo | Catawba Research (India) Private Limited |
| Subhashchandra Pandey DIN 11198164 | Additional Director | 28 Jul 2025 | 1 yr 3 mo | Catawba Research (India) Private Limited |
People of Catawba Research
15 people are tracked at Catawba Research (6 in leadership, 9 in team); the tracked headcount is 21.
| Name | Role | Group |
|---|---|---|
Jason Dean | CFO | Leadership |
Jack McLane | Chief Scientific Officer | Leadership |
Julie Arnold | Vice President, Project Management | Leadership |
| Chief Executive Officer | Leadership | |
Wendy (Mock) Johnson | Director of Human Resources and Culture | Leadership |
John (Jack) McLane | Chief Scientific Officer | Leadership |
Alex Blough | Senior Project Manager | Team |
Tejal Tayade | Clinical Research Associate I | Team |
Zaidoon A. Al-Zubaidy | Executive Chairman Of The Board | Team |
Richard Folnsbee | Manager of Administration Services | Team |
Martin Barry | Sr. CRA | Team |
Habeeb Olalekan Alamutu | Clinical Research Associate II | Team |
Luis Cuza | Manager Clinical Monitoring | Team |
Kevin Irizarry | Assistant Project Manager | Team |
Latondra Morrow | Clinical Trial Specialist | Team |
Complete people profiles for Catawba Research
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Catawba Research
Figures of Catawba Research (India) Private Limited, the primary company behind Catawba Research, for FY 2025. Revenue was ₹9.86 Cr (-2% year on year). Net profit was ₹19.8 Lakh (2% margin). EBITDA was ₹24.2 Lakh (2% margin). Revenue has grown at a compounded annual rate of +18% over three years and +125% over five years.
- ₹9.86 CrRevenue · FY 2025 · -2% YoY
- ₹19.8 LakhNet profit · 2% margin
- ₹24.2 LakhEBITDA · 2% margin
- ₹35 LakhPaid-up capital
- 21Employees (provident fund records)
- +18%Revenue CAGR, 3 years
- +125%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Catawba Research (India) Private Limited are on its company page.
Detailed financial statements for Catawba Research
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Catawba Research
2 dated milestones of Catawba Research across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Catawba Research is founded.
- Funding First funding round.
Competitors of Catawba Research
Catawba Research has 3 listed competitors in our database, 2 of them funded. They include Celgene, Syneos Health and Medelis WCCT Global.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. |
Detailed competitors of Catawba Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Catawba Research
The website of Catawba Research (catawbaresearch.com) receives about 3.5K visits a month.
- Monthly visits3.5K
▲ 3.1% vs previous month
Websites whose visitors overlap most with Catawba Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| saperebio.com | 100% | View details | |||
| altisbiosystems.com | 100% | 16.6K | #1,779,798 | View details | |
| lifeeditinc.com | 96% | View details | |||
| xilis.com | 93% | 2.5K | #6,836,474 | View details | |
| kriyatherapeutics.com | 76% | 8.3K | #2,376,825 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Catawba Research (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Catawba Research
Complete news archive for Catawba Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Catawba Research
Catawba Research was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Catawba Research is headquartered in Charlotte, United States. It is registered at Charlotte, North Carolina, United States.
Catawba Research has 21 employees.
The primary company behind Catawba Research, Catawba Research (India) Private Limited, reported revenue of ₹9.86 Cr for FY 2025, down 2% year on year.
Founded in 2014 and based in Charlotte, United States, Catawba Research operates in the clinical research sector. Services encompass full development support across therapeutic areas, including trial management and clinical operations. Adherence to international good clinical practice guidelines and regulatory requirements is maintained. Scientific and regulatory advisory services are provided through an expert advisory board, covering the clinical development process from program design to market authorization.
Catawba Research's top competitors include Syneos Health, Medelis WCCT Global and Celgene.
Catawba Research offers Trial Management, Clinical Operations, and Therapeutic Expertise.
Catawba Research has 1 investor. Key investors include St. Cloud Capital.
Catawba Research operates through Catawba Research (India) Private Limited.
The legal entities of Catawba Research currently have 3 directors, including Nicolaus Goldstein Joseph, Andrew Flint Silverman, Subhashchandra Pandey.